SLSBio(Specialty Lab Solution Bio) Co., Ltd Logo

SLSBio(Specialty Lab Solution Bio) Co., Ltd

Provides pharma lab services, clinical trial analysis, and innovative diagnostic products.

246250 | KO

Overview

Corporate Details

ISIN(s):
KR7246250005
LEI:
Country:
South Korea
Address:
경기도 수원시 영통구 창룡대로 260, 광교센트럴비즈타워7층 (이의동), 수원시
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

SLSBio (Specialty Lab Solution Bio) Co., Ltd. is a life sciences company that provides a range of specialized services to the pharmaceutical and healthcare industries. The company's core offerings include pharmaceutical quality control, clinical trial sample analysis, bioequivalence testing, and new drug development support. In addition to its contract research services, SLSBio develops diagnostic technologies and test kits, leveraging its proprietary 'NTMD-Technology' platform to create innovative diagnostic products. The company's mission is to contribute to the enhancement of human health through its advanced laboratory solutions and dedicated research.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-08 00:00
Delisting Announcement
기타시장안내 (기업심사위원회 개최 결과 안내)
Korean 3.3 KB
2025-09-08 00:00
Delisting Announcement
주권매매거래정지기간변경 (상장폐지 사유 발생)
Korean 4.9 KB
2025-09-04 00:00
Legal Proceedings Report
[기재정정]주요사항보고서(영업정지)
Korean 12.3 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 697.3 KB
2025-08-11 00:00
Delisting Announcement
기타시장안내 (개선계획서 제출)
Korean 4.1 KB
2025-08-04 00:00
M&A Activity
[기재정정]주요사항보고서(유형자산양수결정)
Korean 22.3 KB
2025-07-21 00:00
Delisting Announcement
기타시장안내 (상장적격성 실질심사 대상 결정)
Korean 4.9 KB
2025-07-21 00:00
Delisting Announcement
주권매매거래정지기간변경 (상장적격성 실질심사 대상 결정)
Korean 4.7 KB
2025-06-30 00:00
Regulatory News Service
기타시장안내 (실질심사 대상여부 결정을 위한 조사기간 연장 안내)
Korean 3.3 KB
2025-06-30 00:00
Legal Proceedings Report
[기재정정]주요사항보고서(영업정지)
Korean 12.7 KB
2025-06-11 00:00
Legal Proceedings Report
[기재정정]주요사항보고서(영업정지)
Korean 13.9 KB
2025-06-10 00:00
Legal Proceedings Report
주요사항보고서(영업정지)
Korean 9.3 KB
2025-06-10 00:00
Regulatory News Service
기타시장안내 (상장적격성 실질심사 대상결정 기한 안내)
Korean 3.0 KB
2025-06-09 00:00
Delisting Announcement
기타시장안내 (상장적격성 실질심사 관련 안내)
Korean 2.8 KB
2025-06-09 00:00
Delisting Announcement
주권매매거래정지 (상장적격성 실질심사 대상 (사유발생))
Korean 4.6 KB

Automate Your Workflow. Get a real-time feed of all SLSBio(Specialty Lab Solution Bio) Co., Ltd filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for SLSBio(Specialty Lab Solution Bio) Co., Ltd

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for SLSBio(Specialty Lab Solution Bio) Co., Ltd via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

ECHOMARKETING Co.,Ltd. Logo
Global agency accelerating sales with data-driven, full-funnel digital marketing.
South Korea
230360
Eezy Oyj Logo
HR services firm for the full employment lifecycle, from recruitment to freelancer support.
Finland
EEZY
Elicio Therapeutics, Inc. Logo
Develops lymph node-targeted immunotherapies for aggressive, KRAS-driven cancers.
United States of America
ELTX
enCore Energy Corp. Logo
American uranium producer using ISR technology to fuel the U.S. nuclear energy sector.
United States of America
EU
ENERGY FUELS INC Logo
A leading U.S. producer of uranium and rare earth elements for EVs, defense, and technology.
United States of America
UUUU
ENIGMATIG LTD Logo
Global expansion and regulatory compliance consultancy for the financial services industry.
United States of America
EGG
Enjin Co., Ltd. Logo
PR firm for SMEs and medical institutions, offering consulting and a media matching platform.
Japan
7370
Ensol Biosciences Inc. Logo
Develops AI-discovered peptide drugs for cancer, osteoarthritis, and Alzheimer's disease.
South Korea
140610
Enveric Biosciences, Inc. Logo
Develops novel neuroplastogen drugs for severe mental health and addiction disorders.
United States of America
ENVB
Eutilex Co.,Ltd. Logo
Develops T-cell and antibody immunotherapies for cancer and autoimmune diseases.
South Korea
263050

Talk to a Data Expert

Have a question? We'll get back to you promptly.